ChemicalBook >> CAS DataBase List >>(16α)-21-Chloro-17-[(2-furanylcarbonyl)oxy]-16-Methyl-pregna-1,4-diene-3,11,20-trione
(16α)-21-Chloro-17-[(2-furanylcarbonyl)oxy]-16-Methyl-pregna-1,4-diene-3,11,20-trione suppliers
(16α)-21-Chloro-17-[(2-furanylcarbonyl)oxy]-16-Methyl-pregna-1,4-diene-3,11,20-trione
- CAS:
- 1305334-31-9
- MF:
- C27H29ClO6
- MW:
- 484.97
Suppliers by country/region
Company Type
Properties
- Melting point:
- >123°C (dec.)
- Boiling point:
- 631.6±55.0 °C(Predicted)
- Density
- 1.32±0.1 g/cm3(Predicted)
- storage temp.
- -20°C Freezer, Under Inert Atmosphere
- solubility
- Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
- form
- Solid
- color
- White to Light Yellow
Safety Information
Use
As impurity of Mometasone Furoate, (16α)-21-Chloro-17-[(2-furanylcarbonyl)oxy]-16-Methyl-pregna-1,4-diene-3,11,20-trione can be used as a topical corticosteroid used as an anti-inflammatory.
44 supplier list of "(16α)-21-Chloro-17-[(2-furanylcarbonyl)oxy]-16-Methyl-pregna-1,4-diene-3,11,20-trione"
$0.00-0.00 / 10mg
- Product Name:Mometasone Furoate EP Impurity C
- Products Intro:Purity: 0.98|Package: 10mg;0.00;USD|25mg;0.00;USD
- Company Type: Trader
- Country/Region: CHINA
- Main Products: drug standards,drug impurity reference substances,chemical reagents,in stock
![Mometasone Furoate EP Impurity C](/images/pro-3.jpg)
- Product Name:Mometasone Furoate EP Impurity C
- Products Intro:Purity: 98% | Package: 1 kg,5 kg, 10 kg,25kg and 1 MT
- Company Type: Reagent
- Country/Region: INDIA
![Mometasone Furoate EP Impurity C](/images/pro-3.jpg)
- Product Name:Mometasone Furoate EP Impurity C
- Products Intro:Purity: 98% | Package: 25mg, 50mg,100mg,200mg
- Company Type: Manufacturer
- Country/Region: INDIA
You can find (16α)-21-Chloro-17-[(2-furanylcarbonyl)oxy]-16-Methyl-pregna-1,4-diene-3,11,20-trione suppliers,
manufacturers, and distributors from countries such as CHINA, India and the Canada here.
Browse to the tetrahydrofuran product information displayed by the supplier,
as well as the supplier's contact and capability information.